GBD 2015 DALYs and HALE Collaborators (2016) Global, Regional, and National Disability-Adjusted Life-Years (DALYs) for 315 Diseases and Injuries and Healthy Life Expectancy (HALE), 1990-2015: A Systematic Analysis for the Global Burden of Disease Study 2015. The Lancet, 388, 1603-1658.
https://doi.org/10.1016/S0140-6736(16)31460-X

has been cited by the following article:

• TITLE: Comparison of Age and Gender Differences of Tryptophan Metabolites in Patients of Major Monopolar and Bipolar Depression

  AUTHORS: Hiroi Tomioka, Junichi Masuda, Akikazu Takada, Akira Iwanami

  KEYWORDS: Depression, Monopolar Depression, Bipolar Depression, Tryptophan, Serotonin, 5-Hydroxyindole Acetic Acid, Kynurenine, 3-Hydroxykynurenine, Kynurenic Acid, Anthranilic Acid, Xanthurenic Acid, Indole-3-Acetic Acid, SSRI (Selective Serotonin Reuptake Inhibitor), SNRI (Serotonin Norepinephrine Reuptake Inhibitor), Anxiolytic, Antipsychotic

  JOURNAL NAME: Food and Nutrition Sciences, Vol.11 No.3, March 5, 2020

  ABSTRACT: Background: No research has been done for the determination of plasma levels of tryptophan metabolites in patients of monopolar and bipolar depression. Methods: Ultra high-speed liquid chromatography/mass spectrometry has been used for the simultaneous determination of plasma levels of tryptophan metabolites in depressive patients. Results: No significant age and gender differences were shown in monopolar depressive patients and some differences were shown in bipolar patients. The administration of drugs such as antidepressants, antipsychotics, mood stabilizers do not seem to have affected the results. Conclusion: In patients of major monopolar depression age and gender differences of plasma levels of tryptophan metabolites disappear although significant differences are observed in healthy volunteers. Some differences of age and gender differences were shown between monopolar and bipolar depressive patients.